Change in the risk stratification of prostate cancer after Slide Review by a uropathologist: the experience of a reference center for the treatment of prostate cancer
Introduction Brachytherapy is an option for treating low-risk prostate cancer (PC). Biochemical control of low-risk disease can reach 95%. The practice advocated is that a review of prostate biopsies should be mandatory before choosing the best treatment for patients with PC. Our objective was to e...
Main Authors: | George Camara-Lopes, Gustavo Nader Marta, Elton Trigo Teixeira Leite, Gabriela Silva Moreira de Siqueira, Samir Abdallah Hanna, João Luis Fernandes da Silva, L. H. Camara-Lopes, Katia R. M. Leite |
---|---|
Format: | Article |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2014-08-01
|
Series: | International Brazilian Journal of Urology |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382014000400454&lng=en&tlng=en |
Similar Items
-
Recovery of hormone sensitivity after salvage brachytherapy for hormone refractory localized prostate cancer
by: Dan Smith, et al.
Published: (2010-06-01) -
External beam radiation therapy and a low-dose-rate brachytherapy boost without or with androgen deprivation therapy for prostate cancer
by: Tobin J. Strom, et al.
Published: (2014-08-01) -
Androgen receptor and prostate cancer
by: Karen E. Livermore, et al.
Published: (2016-06-01) -
SUBSTITUTION ANDROGEN THERAPY AFTER RADICAL TREATMENT OF PROSTATE CANCER
by: T. Kh. Nazarov, et al.
Published: (2018-05-01) -
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
by: Yong Luo, et al.
Published: (2018-06-01)